Development and validation of a scale to assess hesitancy towards new vaccines | ||||
| The Egyptian Journal of Community Medicine | ||||
| Article 3, Volume 40, Issue 4, October 2022, Page 243-250 PDF (362.99 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejcm.2022.115288.1203 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Huny Bakry   1; Noha Abdelsalam2; Eman Waly 3
| ||||
| 1Zagazig University, Department of community medicine | ||||
| 2Zagazig University, faculty of medicine, community medicine department | ||||
| 3Zagazig University, Faculty of Medicine, Community Medicine Department | ||||
| Abstract | ||||
| Background: Assessing the hesitancy towards a new vaccine is of worldwide concern, as a delay in vaccination may give rise to the development of new mutant variants that can attack immunity conferred by previous infection or vaccine. Aim: This study aimed to design and validate a scale to assess the hesitancy towards newly produced vaccine based on health belief model traditional variables with application on COVID-19 vaccines. Methods: A cross sectional study was conducted among heterogeneous group of Egyptian citizens above 18 years old. A survey was distributed on social media platforms between June 1, 2021, and June 30, 2021. The design and evaluation of the scale went through three phases: item development, scale development, and evaluation. Results: The sampling adequacy of Kaiser-Meyer-Olkin measure was 0.8 at significance level of Bartlett's test of sphericity Conclusion: The designed scale to assess hesitancy towards new vaccines based on health belief model was valid among the studied population; also, it was a reliable scale according to Cronbach’s alpha. | ||||
| Keywords | ||||
| vaccine hesitancy; new vaccines; scale validation | ||||
|
Statistics Article View: 216 PDF Download: 195 |
||||
